本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Galmed Pharmaceuticals Ltd.

1.83
+0.260916.62%
成交量:5,640.00万
成交额:1.29亿
市值:413.42万
市盈率:-0.23
高:2.67
开:2.50
低:1.82
收:1.57
数据加载中...
2025/04/03

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/20

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/29

SEC问询函

Form CORRESP - Correspondence
2024/10/21

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/09/20

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/20

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/09

SEC问询函

Form CORRESP - Correspondence
2024/08/30

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/04/04

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/07/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/14

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/07/13

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/07/12

SEC问询函

Form CORRESP - Correspondence
2023/07/12

SEC问询函

Form CORRESP - Correspondence
2023/06/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses